UBS Group’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $750K | Buy |
|
|||||
|
2025
Q2 | $361K | Sell |
|
|||||
|
2025
Q1 | $555K | Buy |
|
|||||
|
2024
Q4 | $460K | Buy |
|
|||||
|
2024
Q3 | $265K | Buy |
|
|||||
|
2024
Q2 | $194K | Sell |
|
|||||
|
2024
Q1 | $404K | Buy |
|
|||||
|
2023
Q4 | $449K | Buy |
|
|||||
|
2023
Q3 | $203K | Sell |
|
|||||
|
2023
Q2 | $326K | Buy |
|
|||||
|
2023
Q1 | $258K | Buy |
|
|||||
|
2022
Q4 | $239K | Buy |
|
|||||
|
2022
Q3 | $71K | Sell |
|
|||||
|
2022
Q2 | $91K | Buy |
|
|||||
|
2022
Q1 | $20K | Sell |
|
|||||
|
2021
Q4 | $445K | Buy |
|
|||||
|
2021
Q3 | $113K | Buy |
|